| 0 (0%) | 11-11 17:45 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.15 | 1-year : | 5.04 |
| Resists | First : | 3.55 | Second : | 4.32 |
| Pivot price | 3.15  |
|||
| Supports | First : | 2.33 | Second : | 1.93 |
| MAs | MA(5) : | 2.82  |
MA(20) : | 3.25 |
| MA(100) : | 3.54 |
MA(250) : | 4.44 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 27.2 |
D(3) : | 23.8 |
| RSI | RSI(14): 40.9 |
|||
| 52-week | High : | 7.21 | Low : | 2.33 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ HHS ] has closed above bottom band by 37.8%. Bollinger Bands are 160.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 3 - 3.02 | 3.02 - 3.03 |
| Low: | 2.78 - 2.79 | 2.79 - 2.81 |
| Close: | 2.97 - 2.99 | 2.99 - 3.01 |
Tue, 11 Nov 2025
Trump cares about ballrooms and billionaires, not Americans' health care: Fmr. HHS Secy. - MSNBC News
Tue, 11 Nov 2025
HHS Removes Misleading Safety Warning Information on Menopausal Hormone Therapy Label - Pharmaceutical Executive
Mon, 10 Nov 2025
FDA Will Remove Warnings for HRT Products Used for Menopause - MedCity News
Mon, 10 Nov 2025
Trump HHS Nixes Biden-Era Rule Incentivizing Doctors to Formulate ‘Anti-Racism’ Plans - National Review
Mon, 10 Nov 2025
HHS Secretary RFK Jr: This black box warning has 'frightened' people, should have never been put on - Fox News
Mon, 10 Nov 2025
FDA removing warnings from hormone replacement therapy products - The Hill
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 7 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 47.4 (%) |
| Held by Institutions | 31.8 (%) |
| Shares Short | 12 (K) |
| Shares Short P.Month | 20 (K) |
| EPS | -0.39 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3 |
| Profit Margin | -1.8 % |
| Operating Margin | -0.2 % |
| Return on Assets (ttm) | 2.5 % |
| Return on Equity (ttm) | -14.1 % |
| Qtrly Rev. Growth | -14.2 % |
| Gross Profit (p.s.) | 4.19 |
| Sales Per Share | 23.6 |
| EBITDA (p.s.) | 1.17 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -5 (M) |
| Levered Free Cash Flow | -1 (M) |
| PE Ratio | -7.67 |
| PEG Ratio | 0 |
| Price to Book value | 0.99 |
| Price to Sales | 0.12 |
| Price to Cash Flow | -4.85 |
| Dividend | 0.85 |
| Forward Dividend | 0 |
| Dividend Yield | 28.4% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|